Z79.818 – Long term (current) use of other agents affecting estrogen receptors and estrogen levels
Coding Notes
Active
Billable, valid for HIPAA-covered transactions
Applicable To
Long term (current) use of estrogen receptor downregulators
Long term (current) use of fulvestrant (Faslodex)
Long term (current) use of gonadotropin-releasing hormone (GnRH) agonist
Long term (current) use of goserelin acetate (Zoladex)
Long term (current) use of leuprolide acetate (leuprorelin) (Lupron)
Long term (current) use of megestrol acetate (Megace)
GEM Conversion to ICD-9 CM
MDC / MS-DRG Reference
Back Reference of Diagnostic Codes
Long-term
(current) (prophylactic) drug therapy (use of)
fulvestrant
(Faslodex)
Z79.818
goserelin acetate
(Zoladex)
Z79.818
leuprolide acetate
(leuprorelin) (Lupron)
Z79.818
megestrol acetate
(Megace)
Z79.818
Therapy
drug, long-term
(current) (prophylactic)
fulvestrant
(Faslodex)
Z79.818
goserelin acetate
(Zoladex)
Z79.818
leuprolide acetate
(leuprorelin) (Lupron)
Z79.818
megestrol acetate
(Megace)
Z79.818
Sibling Codes
Parent Sibling Codes
Codes with Same Suffix
View in Tabular
Code | Title |
---|---|
Z00-Z99 | Factors influencing health status and contact with health services (Z00-Z99) |
Z77-Z99 | Persons with potential health hazards related to family and personal history and certain conditions influencing health status (Z77-Z99) |
Z79 | Long term (current) drug therapy |
Z79.8 | Other long term (current) drug therapy |
Z79.81 | Long term (current) use of agents affecting estrogen receptors and estrogen levels |
Z79.818 |
Long term (current) use of other agents affecting estrogen receptors and estrogen levels
Applicable to
Long term (current) use of estrogen receptor downregulators
Long term (current) use of fulvestrant (Faslodex)
Long term (current) use of gonadotropin-releasing hormone (GnRH) agonist
Long term (current) use of goserelin acetate (Zoladex)
Long term (current) use of leuprolide acetate (leuprorelin) (Lupron)
Long term (current) use of megestrol acetate (Megace)
|